Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade

References

Page 1

	Year	Citations
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, International Journal of Cancer Mortality WorldwideCancer ManagementEpidemiology Of CancerPathologyCancer Incidence	2014	28.8K
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, New England Journal of Medicine	2016	9.8K
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo, Science Tumor ImmunologyCancer ImmunosurveillanceAdaptive Immune ResponseMedicineImmunology	2006	6.3K
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, New England Journal of Medicine	2012	5.3K
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation Caroline Robert, Georgina V. Long, Benjamin Brady, New England Journal of Medicine	2014	5.3K
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection Shawn D. Blackburn, Haina Shin, W. Nicholas Haining, Nature Immunology Viral PersistenceImmunologyAntiviral ResponseVirologyAutoimmunity	2008	2K
The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin Laura K. Mackay, Azad Rahimpour, Z. Joel, Nature Immunology Skin DevelopmentDevelopmental BiologyDevelopmental PathwayLymphocyte DevelopmentT-regulatory Cell	2013	1.3K
Esophageal Carcinoma Anil K. Rustgi, Hashem B. El‐Serag New England Journal of Medicine EsophagusEsophageal CancerMedicinePathology5-Year Survival Rate	2014	1.2K
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors Alena Gros, Paul F. Robbins, Xin Yao, Journal of Clinical Investigation	2014	1.1K
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors Thomas Duhen, Rebekka Duhen, Ryan Montler, Nature Communications	2018	903

Page 1